/
Stem Cells & PRP in Stem Cells & PRP in

Stem Cells & PRP in - PowerPoint Presentation

bagony
bagony . @bagony
Follow
355 views
Uploaded On 2020-06-16

Stem Cells & PRP in - PPT Presentation

Sports Medicine Dr Pete Biglin DO Conflict of Interest In compliance with continuing education requirements all presenters must disclose any financial or other associations with companies to which they have a direct link andor financial relationship that is related to the topiccontent of t ID: 779230

stem cells prp amp cells stem amp prp cell bone tissue sports adult marrow potential knee blood healing studies

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "Stem Cells & PRP in" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Stem Cells & PRP in

Sports Medicine

Dr. Pete Biglin, DO

Slide2

Conflict of Interest

In compliance with continuing education requirements, all presenters must disclose any financial or other associations with companies to which they have a direct link and/or financial relationship that is related to the topic/content of their presentation.

None

Slide3

Overview of Healing process

TYPE OF HEALING:

EXAMPLES:

Biologic-natural

Humans “regenerate” cells on a daily basis to replenish body systems. Tissues regenerate naturally- even the elderly. Humans have intrinsic capability of healing.

Rehabilitation

Can facilitate healing response. Examples: ROM, stretching, strengthening, cross fiber massage, eccentric loading

Surgical repairACL repair, ORIF………etc.Othernutrition, chiropractic, acupuncture…….etc.Experimental “Orthobiologics”Platelet Rich Plasma, and Stem cell treatments

PM&R 7 (2015) S1-3

Slide4

“Orthobiologics”- can we harness our bodies healing capacity?Various biologic agents obtained directly from our own bodies taping into our own intrinsic capacity to heal

Treatment of various orthopedic conditions is possibleExact mechanism of action is unknownBasic science evidence points more toward enhancing local environment, & upregulating healing factors – as opposed to replacing new tissues Types:Platelet Rich Plasma (PRP)

Stem Cell Treatments

PM&R 7 (2015) S1-3)

Slide5

Stem Cell Treatments

Slide6

What are Stem Cells?

Slide7

TYPE OF STEM

CELL

:

WHAT IT CAN BE

:

EXAMPLES

:

TOTIPOTENT

CELLS

NEW HUMAN

CELLS OF THE EMBRYO

1-3 DAYS

PLURIPOTENT CELLS

ANY CELL

TYPE

CELLS OF BLASTOCYST 5-14 DAYS

MULTIPOTENT CELLS

(ADULT STEM CELLS)

MANY DIFFERENT

TISSUE CELL TYPES

MATURE

FETUS, CORD BLOOD & ADULT CELLS

TOTIPOTENT EMBRYONIC CELL

PLURIPOTENT CELL TYPES:

ENDODERM

MESODERM

ECTODERM

ORGANS

HEART,BLOOD

*MUSCLE, SKIN, BONE

MESENCHYMAL STEM CELLS (MSC)

BASIC SCIENCE OF STEM CELLS

Slide8

TOTIPOTENT CELLS

&PLURIPOTENT CELLS

(EMBRYO)

MULTIPOTENT CELLS

(ADULT

STEM CELLS)

PROS

EASY TO ISOLATEUNLIMITED SELF RENEWALLESS LIKELY TISSUE REJECTIONLESS ETHICAL ISSUESSAFER?

CONS

RISK

OF TISSUE REJECTION

ETHICAL ISSUES (EMBRYO)

POSSIBLE TERATOMA (TUMOR) FORMATION

HARD TO ISOLATE

LIMITED DIFFERENTIATON

Slide9

ADULT STEM CELLS-MSCDifferentiation or “MULTIPOTENCY potential”:

Osteoblasts (bone, cartilage)Adipocytes (fat)Chondrocytes (cartilage)Myocytes (muscle)Neurons (nerve)

Slide10

INDUCED PLURIPOTENT

STEM CELLS (iPS):

Lab techniques transforming adult stem cells to “Pluripotent” for research . Animal studies currently.

nih.gov

Slide11

ADULT STEM CELL-Sources

Bone MarrowUmbilical CordAdipose tissueMolar Cells (teeth)

BMAC Procedure

Slide12

Potential Stem Cell Uses in Sports

Ligament TendonCartilageMuscle tissueSpine

Slide13

Other potential uses for Stem CellsStroke

Brain injuryAlzheimer’sMissing teethWound healingBone marrow transplantsSpinal cord injury

OA, RA

Nonunion fractures*

Baldness

Blindness

ALS

Heart attacksMuscular DystrophyDiabetesMSCancer

Slide14

ADULT STEM CELL DELIVERY

Sources (harvesting):BMAC-bone marrow aspiration concentrate (autologous)

Fat cell liposuction (autologous)

Cryogenic stored Umbilical cord blood from a donor (allogeneic

)

Delivery Process

:

Intravenous (e.g. Cancer treatment)Local delivery (e.g. injection into joint or ligament)

Slide15

BONE MARROW HARVESTING

15-20 minute office based procedure

Done with local anesthetic

60-90 cc obtained-yields 4cc BMAC after centrifuge

Slide16

BONE MARROW (

STEM CELLS

)

AND/OR

PERIPHERAL BLOOD (

PRP

)

CENTRIFUGE

INJECT

Slide17

Mayo Clinic study August 2016

1

st

ever

prospective, blinded, placebo controlled

clinical study to test bone marrow adult stem cells to reduce knee pain

American Journal Sports Medicine Aug 2016

Slide18

Mayo Clinic study August 2016

Methods:25 patientsBMAC one knee & Saline injected contralateralPain score 1 week, 3 mo. & 6 mo.

Results:

No adverse events

Pain relief ”dramatic” in BOTH knees

American Journal Sports Medicine Aug 2016

Slide19

Mayo Clinic study August 2016Conclusions:BMAC procedure is SAFE

Pain relief similar in BOTH knees-making results somewhat uninterpretableFuture studies needed:Mechanism or actionDuration of efficacyFrequency of treatmentsRegenerative potential to regrow cartilage etc.

American Journal Sports Medicine Aug 2016

Slide20

SOME

STEM CELL STUDIESBODY PARTNOTES

Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose g

raft. Biomed Res Int. 2014;2014:e370621

KNEE OA

840 procedures,

Encouraging

outcomeLow rate AEsNo added benefit with adiposeA Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. American Journal Sports Med. August 2016KNEE OA1st ever prospective, blinded, placebo controlled clinical study

Concentrated Bone Marrow Aspirate for the Treatment of Chondral Injuries and Osteoarthritis of the Knee

A Systematic Review of Outcomes

KNEE

OA

Lack of high quality studies

Level of evidence 4

Most studies showing a safe procedure with good results

Slide21

ADULT STEM CELLSOPEN Scientific Questions

:“Homing” (peripheral IV or local injection)Culturing –growing more stem cells (currently FDA restricted)Applications (Diagnosis specific) Mechanism of Action (surface receptors)

Possible Cancer progression

not shown with adult stem cells

Immune reactions (allogeneic donor)

Slide22

Current FDA restrictions on Stem CellsFDA restrictions prevent manipulation of culture expansion of stem cells.Adipose tissue- can have higher #s of MSC

– however, isolating the stem cells requires enzymatic digestion of the aspirated adipose tissue, which is currently prohibited by the FDABottom line: Stem Cells can be harvested but not manipulated -“more than minimal” ; Centrifuge, adding water, crystalloids, cutting and shaping of autologous cells is allowed – thereby exempt

from FDA regulation.

PM&R 7. (2015) S60-S65

Slide23

PRP Treatments

Slide24

What is PRP “Platelet Rich Plasma” ?Derived from peripheral blood draw (60 cc) which is then placed in a centrifuge yielding plasma with concentrated number of platelets (3-4 cc)

Potential benefits:Promote the body’s healingRemove scar tissue

Promote tissue regeneration

Reduce inflammation

Slide25

Potential PRP Mechanism of Action?

Therapeutic potential of PRP based on growth factors released from platelets in “supraphysiologic” amounts that can augment the body’s natural healing response.Growth factors from PLT (released from alpha granules) attract stem cells, macrophages, fibroblasts cells promote removal of degenerated/necrotic tissue and enhance tissue regeneration and healingPlatelets also contain signal proteins, growth factors, chemokines, cytokines, and bioactive factors that initiate & regulate the inflammatory cascade.

PM&R (2015) S53-S59

Slide26

Centrifuge of Blood- PRP injectionsGoals:

Maximize Platelet ConcentrationMinimize RBC % (possibly cytotoxic to cartilage cells)Minimize WBC % - if doing intra-articular injections. However, WBC may need to be increased in soft tissue injections for potential debridement aspects (Macrophage stimulation)

Centrifuged

Blood

% WBC & RBC obtained can be modified

PM&R (2015) S535-S59

Slide27

BONE MARROW (

STEM CELLS

)

AND/OR

PERIPHERAL BLOOD (

PRP

)

CENTRIFUGE

INJECT

Slide28

SOME PRP STUDIES

BODY PARTOUTCOME

Treatment of chronic elbow tendonosis with buffered PRP. Am J Sports Med 2006;34:1774-1778

TENNIS ELBOW

BENEFICIAL

PRP significantly improves clinical outcomes in patients with chronic tennis elbow. Am J Sports Med 2014; 42:463-471

TENNIS ELBOW

BENEFICIALTreatment of partial ulnar collateral ligament tears in the elbow with PRP. Am J Sports Med 2013;41;1689-1694ULNAR COLLATERAL LIGAMENTBENEFICIALOne year follow up of PRP treatment in Chronic Achilles tendinopathy: A double blinded randomized placebo controlled trial. Am J Sports Med 2011; 39: 1623-1629 ACHILLES TENDONNOT BENEFICIALActa Chir Orthop Traumatol 2013;80:278-283INTRA-ARTICULAR KNEE INJECTION - OA

PRP SUPERIOR

BENEFIT OVER VISCO-SUPPLEMENTATION

Slide29

ConclusionPRP: showing promise in refractory tendinopathies & the modulation of pain and inflammationStem Cell treatments

: emerging studies that support the potential benefit of mesenchymal stem cells for cartilage disorders including osteoarthritis and other MSK conditionsOrthobiologics are a ”highly touted rookie” with a lot to prove

PM&R 7 (2015) S1-S3